Bank Julius Baer & Co’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Sell
3,273
-481
-13% -$222K ﹤0.01% 341
2026
Q1
$1.74M Sell
3,754
-499
-12% -$255K 0.01% 334
2025
Q4
$2.42M Sell
4,253
-1,217
-22% -$691K 0.01% 305
2025
Q3
$2.81M Buy
5,470
+5,352
+4,536% +$2.34M 0.01% 295
2025
Q2
$36.9K Sell
118
-105
-47% -$31.5K ﹤0.01% 559
2025
Q1
$67.9K Buy
+223
New +$75K ﹤0.01% 519

Other funds holding MEDP

Bank Julius Baer & Co's MEDP Position: Q2 2026 in Review

Bank Julius Baer & Co reduced its Medpace (MEDP) stake by 13% in Q2 2026, selling an estimated $222K and leaving 3,273 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #341.

Bank Julius Baer & Co first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.81M in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bank Julius Baer & Co held 3,273 shares of Medpace worth $1.73M as of Q2 2026.
  • Bank Julius Baer & Co sold 481 Medpace shares in Q2 2026, an estimated $222K.
  • Medpace made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #341 holding.
  • Bank Julius Baer & Co first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Bank Julius Baer & Co's Medpace position peaked at $2.81M in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.